Acorah Software Products - Accounts Production15.0.600truetruefalsetrueNo description of principal activity31 May 202331 May 202431 May 202414905859Ms Andrea Martos Estebaniso4217:GBPiso4217:EURiso4217:USDxbrli:sharesxbrli:purexbrli:pure149058592023-05-30149058592024-05-31149058592023-05-312024-05-3114905859frs-bus:PrivateLimitedCompanyLtd2023-05-312024-05-3114905859frs-bus:FilletedAccounts2023-05-312024-05-3114905859frs-bus:Micro-entities2023-05-312024-05-3114905859frs-bus:EntityHasNeverTraded2023-05-312024-05-3114905859frs-bus:AuditExempt-NoAccountantsReport2023-05-312024-05-3114905859frs-bus:Director12023-05-312024-05-31
Registered number: 14905859
Cambridge Biocapital Ltd
Unaudited Financial Statements
For The Year Ended 31 May 2024
Parry and Parry Limited
Chesterton House
Church Street
Cambridge
CB4 1DT
Cambridge Biocapital Ltd
Balance Sheet
As At 31 May 2024
Balance Sheet
Registered number: 14905859
2024
£
Current assets
100
NET CURRENT ASSETS
100
TOTAL ASSETS LESS CURRENT LIABILITIES
100
NET ASSETS
100
CAPITAL AND RESERVES
100
Notes
1.General Information
Cambridge Biocapital Ltd is a private company, limited by shares, incorporated in England & Wales, registered number 14905859. The registered office is Third Floor, 86-90 Paul Street, London, EC2A 4NE.
2.Average Number of Employees
Average number of employees, including directors, during the year was: NIL
-
For the year ending 31 May 2024 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
The member has not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.
These accounts have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies' regime.